Officials from VCU Massey Comprehensive Cancer Center awarded the center’s first $50,000 harvest grant to the Free Clinic of Powhatan, extending a commitment to the clinic’s “Eat Well, Be Well,” pilot nutrition program.
The Lung Cancer Research Foundation announced funding opportunities to advance lung cancer research, including two new Team Science awards and an Early Career Investigator award.
NCI has initiated a pilot study to address the feasibility of using multi-cancer detection, or MCD, tests in future randomized controlled trials.
The Ohio State University Comprehensive Cancer has launched a first-of-its-kind clinical trial.
Stereotactic brain-directed radiation showed positive outcomes that support the use of targeted radiation in the future, according to a study led by investigators from Mass General Brigham published in the Journal of Clinical Oncology.
A treatment approach using the drug cyclophosphamide can prevent most graft-versus-host disease in blood cancer patients without a donor match, new UVA Cancer Center research reveals.
Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87% of patients with stage 3 melanoma remained alive, according to new results from a study led by researchers at the University of Texas MD Anderson Cancer Center.
The aging process known as senescence is a mechanism involved in the failure of CAR T-cell therapy, according to a study by researchers at the Mayo Clinic.
Specific sequences of chemotherapy, targeted therapy, and immunotherapy yielded significantly different results, according to a study that utilized simulation models and real-world data to predict outcomes under different sequencing scenarios.
Cancer deaths linked to obesity have tripled in the United States over the past two decades, according to a study presented at ENDO 2025 in July.
